S2947
RTT- RTT operational practice and workflow innovations
ESTRO 2026
performed between January 2023 to May 2025.All men having radical prostate radiotherapy from March 2024 were invited to a therapy radiographer led 2hour peer group session, scheduled to occur between the initial oncology visit and subsequent CT planning appointment.The session provided radiotherapy information and education on: Optimising bladder and bowel preparation, psychological support, support charities/services available. Pelvic health physiotherapy and dietetic information was also included.The primary endpoint was the reduction in radiotherapy planning CT rescan rates. Patient satisfaction with the prehab session was obtained via a standardised qualitative patient feedback questionnaire. Results: Between January 2023 and May 2025, 470 men attended for a prostate radiotherapy planning CT scan with 170 pre and 300 post the introduction of the prehab clinic.At least 1 additional planning CT scan was required in 48 (28%) and 70 (23%) of the men in the pre and post prehab clinic cohorts respectively. (figure 1)We therefore observed an absolute difference of 5% points, equating to an 18% relative reduction in rescan rates following the introduction of prehab. 97% of men reported feeling well prepared for their radiotherapy treatment after attending the prehab clinic. (see figure 2) Conclusion: A prehabilitation clinic for men due to attend for radical prostate radiotherapy is widely appreciated and shows an important reduction in the need for repeat planning scans.Ongoing data collection will assess the full impact on service capacity. Patient satisfaction with the prehabilitation clinic was excellent and the target 10% relative reduction in rescans was met.
Keywords: prostate, prehab
Digital Poster Highlight 4419 Inequitable Access to Late Effects Services After Radiotherapy: A National Audit Caroline Fadipe 1 , Marina Khan 1 , Ingrid White 2 1 Radiotherapy, Guys and St Thomas NHS Foundation Trust, London, United Kingdom. 2 Clinical Oncology, Guys and St Thomas NHS Foundation Trust, London, United Kingdom Purpose/Objective: To evaluate the extent to which current provision of therapeutic radiographer (RTT) support related to late effects after pelvic radiotherapy in gynaecological cancer matches existing published consensus guidelines1,2. Material/Methods: In August 2025, 56 UK NHS radiotherapy managers were sent an electronic questionnaire designed to assess compliance with consensus guidelines on the management of late effects after pelvic radiotherapy. A total of 75 questions were included in the questionnaire, focusing on four key areas: (1) use of validated questionnaires for assessing radiotherapy- related toxicity, (2) departmental guidelines, (3) referral pathways, and (4) access to specialist late effects services and expertise. Results: There were 40 (71 %) responses. Of those that responded 54.7 % reported that their department had clear guidelines in the management of late effects and 32.2 % reported that there were established criteria for referring patients on for specialist management. There were clearly defined pathways for referral in 45.1% of responses. A dedicated late effects service for patients with gynaecological cancer treated with pelvic radiotherapy was reported in only 42.5 % of departments; however, this tumour site had the greatest overall provision of late effects clinics. In
Made with FlippingBook - Share PDF online